We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Correlation Between Five Asthma Control Questionnaires

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01350661
First Posted: May 10, 2011
Last Update Posted: August 10, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Dr. Inge Muylle, Centre Hospitalier Universitaire Saint Pierre
  Purpose

This observational study aims to assess the correlation between many questionnaires designed to assess the level of control of asthma. The five questionnaires will be submitted, at the same time and in a random order, to asthma patients. Some other parameters will be recorded (e.g. lung function, epidemiological data). The hypothesis is that the results of the questionnaires will be the same. If not, we will try to understand why.

The investigators will include 100 patients, stratified with relation to their level of asthma severity (25 patients for each level of severity - described by the GINA guidelines).


Condition
Asthma

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Assessment of Correlation Between Five Asthma Control Questionnaires

Further study details as provided by Dr. Inge Muylle, Centre Hospitalier Universitaire Saint Pierre:

Primary Outcome Measures:
  • Level of asthma control [ Time Frame: 1 day ]
    The five questionnaires are completed succesively on the same time.


Enrollment: 99
Study Start Date: June 2010
Study Completion Date: June 2011
Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Asthma control level assessment

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients seen at the consultation of pulmonology of a tertiary hospital.
Criteria

Inclusion Criteria:

  • Diagnosis of asthma confirmed by a pulmonologist
  • Patient have had a lung function testing on the same day than the questionnaires are fulfilled.
  • Age equal or upper than 18 years
  • Agreement to participate to this study

Exclusion Criteria:

  • Age under 18 years
  • Refusal to participate to this study
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01350661


Locations
Belgium
CHU St Pierre; pulmonology department
Brussels, Belgium, 1000
Sponsors and Collaborators
Centre Hospitalier Universitaire Saint Pierre
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Dr. Inge Muylle, Centre Hospitalier Universitaire Saint Pierre
ClinicalTrials.gov Identifier: NCT01350661     History of Changes
Other Study ID Numbers: B07620109010
First Submitted: May 9, 2011
First Posted: May 10, 2011
Last Update Posted: August 10, 2015
Last Verified: August 2015

Keywords provided by Dr. Inge Muylle, Centre Hospitalier Universitaire Saint Pierre:
Asthma
Questionnaires

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases